Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.
During phase II metabolism, a substrate is rendered more hydrophilic through the covalent attachment of an endogenous molecule. The cytosolic sulfotransferase (SULT) and UDP-glucuronosyltransferase (UGT) families of enzymes account for the majority of phase II metabolism in humans and animals. In general, phase II metabolism is considered to be a detoxication process, as sulfate and glucuronide conjugates are more amenable to excretion and elimination than are the parent substrates. However, certain products of phase II metabolism (e.g., unstable sulfate conjugates) are genotoxic. Members of the nuclear receptor superfamily are particularly important regulators of SULT and UGT gene transcription. In metabolically active tissues, increasing evidence supports a major role for lipid-sensing transcription factors, such as peroxisome proliferator-activated receptors (PPARs), in the regulation of rodent and human SULT and UGT gene expression. This review summarizes current information regarding the regulation of these two major classes of phase II metabolizing enzyme by PPARs.
Runge-Morris
Melissa
M
Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48201, USA. m.runge-morris@wayne.edu
Kocarek
Thomas A
TA
Drug Metab Dispos. 2005 Jul;33(7):1017-26
15802387
Drug Metab Dispos. 2005 Jan;33(1):147-56
15502011
Pharmacogenet Genomics. 2007 Dec;17(12):1077-89
18004212
Endocrinology. 2001 Jul;142(7):2978-84
11416019
Curr Drug Metab. 2000 Jul;1(1):1-30
11467078
J Invest Dermatol. 1999 Mar;112(3):303-9
10084306
Pharmacol Ther. 1989;43(2):261-89
2506584
J Pharmacol Exp Ther. 2001 May;297(2):489-95
11303034
Curr Drug Metab. 2005 Aug;6(4):289-98
16101569
Endocrinology. 1993 Nov;133(5):2177-86
8404669
J Steroid Biochem Mol Biol. 1995 Jun;52(6):529-39
7779757
Mutat Res. 2000 Apr;462(2-3):189-95
10767630
J Lipid Res. 1983 Feb;24(2):131-40
6833890
Genomics. 1998 Nov 1;53(3):284-95
9799594
J Invest Dermatol. 1984 Nov;83(5):332-5
6238102
Pharmacol Ther. 2009 Jun;122(3):246-63
19318113
Drug Metab Dispos. 2002 Nov;30(11):1280-7
12386136
Toxicol In Vitro. 2000 Dec;14(6):505-12
11033061
J Clin Endocrinol Metab. 1999 Apr;84(4):1357-64
10199779
Drug Metab Dispos. 2000 Jan;28(1):34-7
10611137
Structure. 2002 Dec;10(12):1697-707
12467577
Xenobiotica. 1987 Apr;17(4):445-57
2885979
Biochem Pharmacol. 1987 Nov 15;36(22):3923-7
3120730
Methods Enzymol. 2005;400:1-22
16399340
Drug Metab Dispos. 2006 Nov;34(11):1887-92
16896063
Biochim Biophys Acta. 1994 Nov 17;1215(1-2):183-9
7948002
Angew Chem Int Ed Engl. 2004 Jul 5;43(27):3526-48
15293241
J Clin Invest. 1998 Sep 1;102(5):1016-23
9727070
Steroids. 1998 May-Jun;63(5-6):322-8
9618795
Drug Metab Dispos. 2002 Dec;30(12):1462-9
12433820
Mol Endocrinol. 2003 Jun;17(6):985-93
12690094
Chem Biol Interact. 1998 Feb 20;109(1-3):329-39
9566756
Dig Liver Dis. 2007 Apr;39(4):351-5
17347060
Biochem Biophys Res Commun. 2000 Oct 14;277(1):236-45
11027669
J Invest Dermatol. 1992 May;98(5):730-3
1349030
J Steroid Biochem Mol Biol. 1999 Jul-Aug;70(1-3):101-8
10529008
J Invest Dermatol. 1989 Feb;92(2):203-9
2465352
Clin Pharmacokinet. 1999 Aug;37(2):91-104
10496299
Biochem J. 2004 May 1;379(Pt 3):533-40
14741047
Mol Pharmacol. 1999 Dec;56(6):1198-206
10570047
Mol Cell Biol. 1998 Sep;18(9):5199-207
9710604
J Biol Chem. 1992 Feb 15;267(5):3257-61
1339448
Clin Sci (Lond). 1984 Apr;66(4):389-97
6697662
Hepatology. 2007 Feb;45(2):422-32
17256725
Drug Metab Dispos. 2006 Oct;34(10):1772-8
16855052
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14033-7
11717462
Biochem Biophys Res Commun. 2001 Oct 19;288(1):280-9
11594786
Brain Res. 2001 Nov 30;920(1-2):222-5
11716829
Biochem J. 1982 Apr 1;203(1):161-8
7103935
FEBS Lett. 2001 Feb 9;490(1-2):39-43
11172807
Drug Metab Dispos. 1999 May;27(5):588-95
10220487
Biochim Biophys Acta. 1985 Oct 17;842(2-3):202-13
3931693
Hepatology. 2006 Aug;44(2):368-78
16871576
Pharmacogenomics J. 2004;4(1):54-65
14676822
Nat Med. 2005 Feb;11(2):153-9
15685171
J Biol Chem. 2003 May 16;278(20):17838-44
12637555
J Biol Chem. 2003 Nov 7;278(45):44593-9
12923182
J Pharmacol Exp Ther. 2006 Mar;316(3):1310-7
16339912
Biochim Biophys Acta. 1996 Mar 15;1289(2):284-90
8600986
Annu Rev Pharmacol Toxicol. 2000;40:159-76
10836131
Xenobiotica. 1987 Jun;17(6):669-77
3114967
Toxicol Appl Pharmacol. 1999 Feb 15;155(1):1-12
10036213
J Toxicol Sci. 2000 Dec;25(5):433-41
11201174
Curr Drug Metab. 2000 Sep;1(2):143-61
11465080
J Histochem Cytochem. 2003 Dec;51(12):1655-64
14623933
J Pharmacol Exp Ther. 2007 Nov;323(2):586-98
17687072
Fertil Steril. 2010 Mar 15;93(5):1538-44
19243756
Anal Biochem. 2003 Dec 1;323(1):139-49
14622968
J Endocrinol. 2001 Dec;171(3):525-32
11739018
Biochem Biophys Res Commun. 2008 Oct 31;375(4):531-5
18725199
J Biol Chem. 2002 Jul 12;277(28):25125-32
11991950
Biochim Biophys Acta. 2005 Jun 20;1724(1-2):119-26
15878639
Mol Cell Biochem. 2009 Jun;326(1-2):3-8
19130183
Biochem Biophys Res Commun. 1998 Jun 29;247(3):681-6
9647753
Carcinogenesis. 1991 Jun;12(6):1145-7
2044198
Fundam Clin Pharmacol. 1988;2(4):259-65
3220422
J Pharmacol Exp Ther. 2008 Feb;324(2):612-21
17993606
Curr Drug Metab. 2008 Feb;9(2):99-105
18288952
J Invest Dermatol. 2004 May;122(5):1207-13
15140224
Pharmacogenetics. 2001 Jun;11(4):357-68
11434514
J Biol Chem. 2003 Aug 29;278(35):32852-60
12810707
Drug Metab Dispos. 2007 Mar;35(3):419-27
17151188
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):214-21
17055258
J Biol Chem. 2002 Sep 27;277(39):36161-6
12145317
Mol Aspects Med. 2009 Jun;30(3):134-52
19248804
Biochem J. 1989 Jun 15;260(3):641-6
2764897
J Invest Dermatol. 1998 Dec;111(6):973-81
9856804
Biochem J. 2000 Mar 15;346 Pt 3:857-64
10698717
Cancer Res. 1996 Apr 1;56(7):1551-5
8603401
Mutat Res. 2001 Oct 1;482(1-2):27-40
11535246
J Clin Endocrinol Metab. 1999 Jul;84(7):2577-80
10404840
Carcinogenesis. 1998 Nov;19(11):2049-53
9855023
Gene. 2006 Feb 15;367:66-73
16368200
Endocrinology. 1991 Sep;129(3):1375-81
1874177
Drug Metab Dispos. 2008 Jan;36(1):51-5
17908920
J Steroid Biochem Mol Biol. 2008 Sep;111(3-5):171-7
18586095
Annu Rev Pharmacol Toxicol. 2000;40:581-616
10836148
Circulation. 2004 Jan 6;109(1):92-6
14676143
Hepatology. 2006 Nov;44(5):1158-70
17058234
J Biol Chem. 2004 May 21;279(21):22250-7
15004017
Arch Biochem Biophys. 1995 Dec 20;324(2):267-72
8554318
Psychoneuroendocrinology. 1998 Nov;23(8):963-87
9924747
Drug Metab Dispos. 2003 Mar;31(3):326-33
12584160
Nature. 1965 Nov 27;208(5013):856-8
5870099
Toxicol Sci. 2006 Mar;90(1):5-22
16322073
Endocrinology. 2003 Apr;144(4):1186-93
12639899
Chem Biol Interact. 1991;77(1):97-105
1898504
Mol Pharmacol. 2005 Apr;67(4):1257-67
15635043
J Biol Chem. 2003 Apr 18;278(16):13975-83
12582161
J Histochem Cytochem. 1973 Nov;21(11):967-71
4587529
Pharmacogenetics. 1992 Jun;2(3):93-108
1306114
Pharmacogenetics. 1997 Aug;7(4):255-69
9295054
Gen Pharmacol. 1989;20(4):407-12
2502468
Neurosci Lett. 2008 Jan 3;430(1):75-80
18054434
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13801-6
12370413
Cell Growth Differ. 1995 Dec;6(12):1619-26
9019167
Drug Metab Pharmacokinet. 2006 Aug;21(4):315-23
16946559
Drug Metab Dispos. 1996 Dec;24(12):1328-35
8971138
Endocr Rev. 2002 Oct;23(5):703-32
12372849
Dev Biol. 1997 Sep 1;189(1):22-32
9281334
J Biol Chem. 2004 Apr 2;279(14):14033-8
14722075
Hepatology. 2007 Jan;45(1):128-38
17187418
J Pharmacol Exp Ther. 2002 Jun;301(3):1042-51
12023536
Steroids. 2001 Jun;66(6):473-9
11182136
J Invest Dermatol. 1998 Dec;111(6):1098-102
9856823
Mol Endocrinol. 2006 Apr;20(4):795-808
16357103
J Clin Endocrinol Metab. 1994 Jan;78(1):234-6
8288708
Biochem Pharmacol. 1977 Mar 15;26(6):547-9
403920
Biochem J. 2001 Jun 15;356(Pt 3):891-7
11389699
J Lipid Res. 2005 Dec;46(12):2657-66
16150827
J Pharmacol Exp Ther. 1995 Jun;273(3):1551-9
7791131
Toxicology. 2004 Nov 15;204(2-3):109-21
15388238
Int J Biochem Cell Biol. 2004 Jul;36(7):1141-6
15109560
Toxicol Appl Pharmacol. 2003 Sep 1;191(2):130-46
12946649
Toxicol Appl Pharmacol. 1992 Aug;115(2):261-7
1641859
J Am Acad Dermatol. 1984 May;10(5 Pt 1):866-8
6586754